175 related articles for article (PubMed ID: 25376976)
1. Risk of bleeding related to selective and non-selective serotonergic antidepressants: a case/non-case approach using data from two pharmacovigilance databases.
Gahr M; Zeiss R; Lang D; Connemann BJ; Hiemke C; Freudenmann RW; Schönfeldt-Lecuona C
Pharmacopsychiatry; 2015 Jan; 48(1):19-24. PubMed ID: 25376976
[TBL] [Abstract][Full Text] [Related]
2. Association between haemorrhages and treatment with selective and non-selective serotonergic antidepressants: Possible implications of quantitative signal detection.
Gahr M; Zeiss R; Lang D; Connemann BJ; Hiemke C; Muche R; Freudenmann RW; Schönfeldt-Lecuona C
Psychiatry Res; 2015 Sep; 229(1-2):257-63. PubMed ID: 26208982
[TBL] [Abstract][Full Text] [Related]
3. Reports of sexual disorders related to serotonin reuptake inhibitors in the French pharmacovigilance database: an example of underreporting.
Trenque T; Maura G; Herlem E; Vallet C; Sole E; Auriche P; Drame M
Drug Saf; 2013 Jul; 36(7):515-9. PubMed ID: 23728950
[TBL] [Abstract][Full Text] [Related]
4. [Antidepressive agents and hyponatremia: A literature review and a case/non-case study in the French Pharmacovigilance database].
Rochoy M; Zakhem-Stachera C; Béné J; Berkhout C; Gautier S;
Therapie; 2018 Oct; 73(5):389-398. PubMed ID: 29773358
[TBL] [Abstract][Full Text] [Related]
5. Selective serotonin reuptake inhibitors and manic switch: A pharmacovigilance and pharmacodynamical study.
Çiray RO; Halaç E; Turan S; Tunçtürk M; Özbek M; Ermiş Ç
Asian J Psychiatr; 2021 Dec; 66():102891. PubMed ID: 34717111
[TBL] [Abstract][Full Text] [Related]
6. Association of antidepressants plus antithrombotics and bleeding risk: a pharmacovigilance study.
Montastruc JL; Bura-Rivière A
Eur J Clin Pharmacol; 2024 Feb; 80(2):283-285. PubMed ID: 38112734
[TBL] [Abstract][Full Text] [Related]
7. Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database.
Pugi A; Bonaiuti R; Maggini V; Moschini M; Tuccori M; Leone R; Rossi M; Motola D; Piccinni C; Ferrazin F; Sottosanti L; Mugelli A; Vannacci A; Lapi F
Am J Health Syst Pharm; 2013 Jun; 70(12):1039-46. PubMed ID: 23719881
[TBL] [Abstract][Full Text] [Related]
8. St John's wort and depression: slight efficacy at best, many drug interactions.
Prescrire Int; 2004 Oct; 13(73):187-92. PubMed ID: 15499702
[TBL] [Abstract][Full Text] [Related]
9. Fluoxetine and Risk of Bleeding in Patients Aged 60 Years and Older Using the Korea Adverse Event Reporting System Database: A Case/Noncase Study.
Kim S; Ko YJ; Park K; Yang BR; Kim MS; Park BJ
J Clin Psychopharmacol; 2019; 39(4):362-366. PubMed ID: 31206390
[TBL] [Abstract][Full Text] [Related]
10. Surveillance of drugs that most frequently induce acute kidney injury: A pharmacovigilance approach.
Hosohata K; Inada A; Oyama S; Furushima D; Yamada H; Iwanaga K
J Clin Pharm Ther; 2019 Feb; 44(1):49-53. PubMed ID: 30014591
[TBL] [Abstract][Full Text] [Related]
11. Risk of Bleeding Associated with Antidepressant Drugs: The Competitive Impact of Antithrombotics in Quantitative Signal Detection.
Zeiss R; Hiemke C; Schönfeldt-Lecuona C; Connemann BJ; Gahr M
Drugs Real World Outcomes; 2021 Dec; 8(4):547-554. PubMed ID: 34117617
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Serotonin Transporter Binding Affinity on the Risk of Bleeding Related to Antidepressants.
Gahr M; Connemann BJ; Muche R; Zeiss R
J Clin Psychopharmacol; 2021 Jul-Aug 01; 41(4):470-473. PubMed ID: 34181363
[TBL] [Abstract][Full Text] [Related]
13. More on the "Triple Whammy": antihypertensive drugs, non-steroidal anti-inflammatory agents and acute kidney injury - a case/non-case study in the French pharmacovigilance database.
Fournier JP; Sommet A; Durrieu G; Poutrain JC; Lapeyre-Mestre M; Montastruc JL;
Ren Fail; 2014 Aug; 36(7):1166-8. PubMed ID: 24826803
[TBL] [Abstract][Full Text] [Related]
14. Safety profiles of adalimumab, etanercept and infliximab: a pharmacovigilance study using a measure of disproportionality in a database of spontaneously reported adverse events.
Mendes D; Alves C; Batel-Marques F
J Clin Pharm Ther; 2014 Jun; 39(3):307-13. PubMed ID: 24635532
[TBL] [Abstract][Full Text] [Related]
15. Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database.
Revet A; Montastruc F; Roussin A; Raynaud JP; Lapeyre-Mestre M; Nguyen TTH
BMC Psychiatry; 2020 Jun; 20(1):308. PubMed ID: 32546134
[TBL] [Abstract][Full Text] [Related]
16. About the cover: St. John's wort.
J Soc Integr Oncol; 2006; 4(1):52-5. PubMed ID: 16737673
[TBL] [Abstract][Full Text] [Related]
17. Signal detection for Thai traditional medicine: examination of national pharmacovigilance data using reporting odds ratio and reported population attributable risk.
Wechwithan S; Suwankesawong W; Sornsrivichai V; McNeil EB; Jiraphongsa C; Chongsuvivatwong V
Regul Toxicol Pharmacol; 2014 Oct; 70(1):407-12. PubMed ID: 24945744
[TBL] [Abstract][Full Text] [Related]
18. [Antidepressive agents and hypertension: A case/no-case study in French pharmacovigilance database].
Hofferer A; Dolladille C; Chretien B; Sassier M; Laugier D; Atzenhoffer M; Bagheri H; Alexandre J; Fedrizzi S; Humbert X
Encephale; 2022 Aug; 48(4):404-408. PubMed ID: 34311965
[TBL] [Abstract][Full Text] [Related]
19. Notoriety bias in a database of spontaneous reports: the example of osteonecrosis of the jaw under bisphosphonate therapy in the French national pharmacovigilance database.
de Boissieu P; Kanagaratnam L; Abou Taam M; Roux MP; Dramé M; Trenque T
Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):989-92. PubMed ID: 24737486
[TBL] [Abstract][Full Text] [Related]
20. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
